Skin cancer
prev Tooltip
Bladder cancer and Photocure Technology®

Bladder cancer and Photocure Technology®

Based on our breakthrough photodynamic technology we have developed a unique product to aid in the diagnosis and management of non-muscle invasive bladder cancer.
Acne
next Tooltip
This information is for healthcare professionals only

Main content

Bladder cancer products

Photocure has developed one product for the detection of bladder cancer. The brand name is Cysview® in the US, and Hexvix® in the rest of the world.
  • Cysview® - Trademark in the US and Canada

    Cysview® - Trademark in the US and Canada
    Cysview® is an optical imaging agent indicated for use in the cystoscopic detection of non-muscle invasive papillary cancer of the bladder among patients suspected or known to have lesion(s) on the basis of a prior cystoscopy. The product is marketed under the trademark Cysview® in the US and Canada.
  • Hexvix® - brand name outside of the US

    Hexvix® - brand name outside of the US
    Hexvix® is an optical imaging agent used for detection of bladder cancer, such as carcinoma in situ, in patients with known bladder cancer or high suspicion of bladder cancer, based on e.g. screening cystoscopy or positive urine cytology.

Right column